300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
SaaS
Restaurants
Film
Photography
Payments
CleanTech
Email
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Mobile
Automotive
Wellness
Education
Sports
Hospitality
Legal
Biotechnology
eSports
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Web3
Social
Cannabis
Beauty
LGBT
Infrastructure
Celebrity
Climate
Mobile Apps
Music
Art
Life Science
Real Estate
Sporting Goods
Wine and Spirits
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Food and Beverage
Non Profit
Internet
Publishing
Android
Sustainability
Hardware
Biotech
Enterprise
Impact
Community
Proptech
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
Canada
United Kingdom
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Qatar
Belgium
Jordan
Barbados
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Austria
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Ethiopia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Mayer Schreiber, CEO at Discovery Park

Mayer Schreiber

CEO @ Discovery Park

Sandwich, United Kingdom

Mayer Schreiber is a pre-seed investor at Discovery Park in Sandwich focused on Life Science and Biotechnology. ceo

Total investments:
4
Last investment:
Lead investor:
25%

Last updated:

Industries Mayer Schreiber invests in

Life ScienceBiotechnologyHealth CareBiopharmaPharmaceutical

Stages Mayer Schreiber invests in

Pre-SeedSeed

Countries Mayer Schreiber invests in

United Kingdom

Investment Focus

Industry

  • Life Science 3 (75%)
  • Biotechnology 3 (75%)
  • Health Care 2 (50%)
  • Biopharma 1 (25%)
  • Pharmaceutical 1 (25%)
See all 6 industries →

Stage

  • Pre-Seed 3 (75%)
  • Seed 1 (25%)

Investments

CompanyDescriptionRoundLinks
BugBiome BugBiome
BugBiome is a biotech start-up offers a revolutionary solution to the age-old problem of mosquito bites. $391.4K / Pre-Seed / Feb 12, 2024
Ignota Labs Ignota Labs
Ignota Labs recognizes that safety errors during the drug discovery process can result in expensive setbacks and delays in bringing life-changing medications to market. Ignota Labs world leading AI methods, which include deep learning and machine learning approaches, are intended to examine complicated molecular data and provide accurate toxicitypredictions. Pre-Seed / Oct 11, 2022
BoobyBiome BoobyBiome
BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. $1.7M / Pre-Seed / Sep 08, 2022
BoobyBiome BoobyBiome
BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. $1.7M / Seed / Mar 29, 2022

Co-Investors

Discovery Park

About Discovery Park

VC Fund · Sandwich, United Kingdom

Discovery Park collaborates with life science companies to bring innovation to healthcare industry.

Discovery Park Contacts

NameEmailPhoneSocials
Rob Mingay
Rob Mingay Senior Vice President NTE or Discovery Park and Senior Consultant Bluestone Government Relations

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Open Discovery Park full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
SaaS
Restaurants
Film
Photography
Payments
CleanTech
Email
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Mobile
Automotive
Wellness
Education
Sports
Hospitality
Legal
Biotechnology
eSports
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Web3
Social
Cannabis
Beauty
LGBT
Infrastructure
Celebrity
Climate
Mobile Apps
Music
Art
Life Science
Real Estate
Sporting Goods
Wine and Spirits
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Food and Beverage
Non Profit
Internet
Publishing
Android
Sustainability
Hardware
Biotech
Enterprise
Impact
Community
Proptech
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
Canada
United Kingdom
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Qatar
Belgium
Jordan
Barbados
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Austria
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Ethiopia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Mayer Schreiber invest in?

Mayer Schreiber invests primarily in Life Science, Biotechnology and Health Care startups, most often at Pre-Seed and Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Mayer Schreiber last invest?

The most recent investment recorded for Mayer Schreiber closed in Feb 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Mayer Schreiber Mayer Schreiber Find email